1-2 sterilisationvalidationqualification (1)

Upload: surendar-kesavan

Post on 13-Apr-2018

216 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    1/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%1

    Sterilization - validation,

    qualification requirements

    Mrs Robyn Isaacson

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    2/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%2

    Sterilization - Overview

    Objectives Discuss definition of Sterile

    !riefly describe sterilization met"ods

    Describe a##roac"es to be used for t"e

    validation of a sterilization #rocess usin$Moist %eat as an e&am#le

    Describe requirements for routine monitorin$

    and control of sterilization

    Review issues t"at are s#ecific to ot"ersterilization #rocesses

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    3/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%3

    Sterile 'roducts - Overview

    (ertain #"armaceutical #roducts must be sterile

    injections, o#"t"almic #re#arations, irri$ations solutions,

    "aemodialysis solutions

    )wo cate$ories of sterile #roducts

    t"ose t"at can be sterilised in final container *terminally

    sterilised+

    t"ose t"at cannot be terminally sterilised and must be

    ase#tically #re#ared

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    4/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%4

    Sterilization - Overview

    "at is t"e definition of sterile

    .ree from microor$anisms

    In #ractice no suc" absolute statement re$ardin$ absence

    of microor$anisms can be #roven

    Defined as t"e #robability of / in a million of a

    container bein$ contaminated */0-1+

    )"is referred to as t"e Sterility 2ssurance 3evel

    *S23+

    Or$anisms are 4illed in an eonential fas"ion

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    5/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%5

    Definition of Sterile

    MI(RO!I23 I52()I62)IO5

    5t7 5oe

    -4t

    0

    200

    400

    600

    800

    1000

    1200

    )ime

    5oofsurvivin$or$anisms

    -2.00

    -1.50

    -1.00

    -0.50

    0.00

    0.50

    1.00

    1.50

    2.00

    2.50

    3.00

    3.50

    No remaining

    Log No remaining

    No remaining 1000 368 135 50 18 7 2 1 0 0 0

    Log No remaining 3.00 2.57 2.13 1.70 1.26 0.83 0.39 -0.04 -0.47 -0.91 -1.34

    0 1 2 3 4 5 6 7 8 9 10

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    6/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%6

    Definition of Sterile

    D-value - )ime *or dose+ required to reduce t"e#o#ulation of or$anisms by / lo$ *or 809+

    D-Value

    Resistance of an or$anism is referred as its D-value

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    7/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%7

    Definition of Sterile

    2 sterilization #rocess must deliver a

    Sterility 2ssurance 3evel *S23+ of / in a

    million */0-1+

    It is not #ossible to measure /0-1

    )"e required S23 can be ac"ieved by

    a##lyin$ a #rocess t"at will reduce t"e

    number of or$anisms to zero and t"ena##ly a safety factor t"at will deliver an

    e&tra 1 lo$ reduction

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    8/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%8

    Definition of Sterile

    :&am#le

    .or an initial bioburden of /0; t"e

    sterilization #rocess will need to

    ac"ieve an < lo$ reduction in

    viable or$anisms

    )"is will require < times t"e D-

    value *e=$= if t"e or$anism "as a

    D value of ; minutes t"en < & ; 7

    /1 minutes will be required to

    ac"ieve an < lo$ reduction andan S23 of /0-1+ *'oint >+

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    9/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%9

    Sterilization - Overview

    (ommonly used met"ods of sterilization Moist %eat

    Dry %eat

    ?as *:t"ylene o&ide+

    Radiation *?amma or :lectron+

    .iltration

    Ot"ers - @6, Steam and formalde"yde,

    "ydro$en #ero&ide

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    10/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%10

    Moist %eat Saturated steam

    (ommon cyclesA /;/B( for /C minutes

    /EB( for minutes

    Ot"er cycles of lower tem#erature and lon$ertime may be used *e=$= //CB( for 0 minutes+

    @sed for sterilization ofA

    terminal sterilization of aqueous injections,

    o#"t"almic #re#arations, irri$ation F"aemodialysis solutions, equi#ment used in

    ase#tic #rocessin$

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    11/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%11

    Moist %eat

    not suitable for non-aqueousGdry

    #re#arations

    #referred met"od of sterilization

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    12/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%12

    Dry %eat

    3et"ality due to o&idative #rocesses %i$"er tem#eratures and lon$er eosure

    times required

    )y#ical cyclesA

    /10B( for /;0 minutes

    /H0B( for 10 minutes

    /

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    13/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%13

    Dry %eat

    @sed forA

    $lassware and #roduct containers used in

    ase#tic manufacture, non aqueous

    t"ermostable #owders and liquids *oils+

    also used for de#yro$enation of $lassware*

    ;C0B(+

    *'yro$ens - substances found in cell wall of

    some bacteria w"ic" can cause fever w"en

    introduced into t"e body+

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    14/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%14

    :t"ylene O&ide ?as

    :it"er #ure or in mi&tures wit" ot"er inert$ases

    Requires #resence of moisture

    (om#le& #rocess

    )y#ical cyclesA

    /-;E"ours

    ;C-/;00 m$G3 $as

    ;C-1CB( 0-

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    15/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%15

    :t"ylene O&ide @sed forA

    "eat labile #roduct containers

    surface sterilization of #owders

    2dequate aeration to reduce to&ic

    residues

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    16/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%16

    Radiation

    ?amma rays $enerated by (obalt 10 or (aesium/H radionuclides or

    2ccelerated electrons from an electron $enerator

    ;C 4ilo$rays *4?y+ usual dose

    dose de#endent on bioburden *resistance of or$anismsnot #redictable+

    #rocess must be #ro#erly validated

    used forA

    dry #"armaceutical #roducts "eat labile #roduct containers

    can cause unacce#table c"an$es

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    17/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%17

    .iltration

    Removes or$anisms from liquids and$asses

    0=; - 0=;; micron for sterilization

    com#osed of cellulose esters or ot"er

    #olymeric materials

    filter material must be com#atible wit"

    liquid bein$ filtered

    used for bul4 liquids, $asses and ventfilters

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    18/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%18

    6alidation - Overview

    Selection of sterilzation #rocess must be

    a##ro#riate for #roduct

    terminal sterilization is t"e met"od of c"oice

    moist "eat *autoclavin$+ is t"e most common

    #rocess used for terminal sterilization #roduct must not be affected by "eat

    containerGclosure inte$rity must be establis"ed

    items bein$ sterilised must contain water *if

    sealed+ or material must allow for removal ofair and #enetration of steam for steam *moist

    "eat+ sterilization

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    19/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%19

    6alidation - 'rotocol

    Requirements for Moist %eat SterilizationOt"er #rocesses follow similar requirements

    6alidation #rotocol s"ould include t"e

    followin$ details for eac" sterilization

    #rocess #rocess objectives in terms of #roduct ty#e,containerGclosure system, S23 required

    s#ecifications for time, tem#erature, #ressure

    and loadin$ #attern descri#tion of all equi#ment and su##ort

    systems in terms of ty#e, model, ca#acity and

    o#eratin$ ran$e

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    20/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%20

    6alidation - 'rotocol

    Moist %eat continuedA

    #erformance c"aracteristics of all equi#ment e=$=

    #ressure $au$es, valves, alarm systems, timers,

    steam flow ratesG#ressures, coolin$ water flow

    rates, cycle controller functions, door closure

    $as4etin$ and air brea4 systems and filters met"odolo$y for monitorin$ #erformance of

    equi#ment and t"e #rocess and labatory testin$

    met"odolo$y

    #ersonnel res#onsible for all sta$es and finalevaluation *s"ould "ave eerience and

    necessary trainin$ and be aut"orized+

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    21/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%21

    6alidation - (alibration

    3aboratory testin$ s"ould be #erformed by a

    com#etent laboratory, met"odolo$y s"ould

    be documented

    2ll instruments must be calibrated e=$=

    tem#erature recorders and sensors t"ermocou#les

    #ressure sensors for jac4et and c"amber

    timers

    conductivity monitors for coolin$ water

    flow metres for waterGsteam water level indicators w"en coolin$ water is used

    t"ermometers includin$ t"ose for t"ermocou#le reference,

    c"amber monitorin$ and laboratory testin$

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    22/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%22

    6alidation - (alibration Indicators s"ould be calibrated

    #"ysical and c"emcial indicators s"ould be testedto demonstrate acce#table res#onse to time and

    tem#erature

    biolo$ical indicators s"ould be tested for count and

    timeGtem#erature eosure res#onse

    for commercial indicators - test certificate wit" countand D-value and eosure res#onse s"ould be

    available= Results acce#table if verified in "ouse

    #eriodically=

    In "ouse indicators must be fully c"aracterized *D-

    value, identification+ and a##ro#riate for sterilization#rocess

    2ll indicators s"ould be a##ro#riately stored and

    wit"in eiry

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    23/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%23

    6alidation - (ycle Develo#ment

    (once#t of .o

    3et"ality factor equivalent to time at /;/B( / minute at /;/B( is equivalent to .o of /=

    3et"ality can accumulate durin$ "eat u# and cooldown #"ases

    Typical temperatre pro!ile o! a "eat #terili$ation proce##

    %"at &ol' (e t"e )o o! a cycle at 121*+ !or 15 minte#,

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    24/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%24

    6alidation - (ycle Develo#ment

    .o is calculated usin$ t"e followin$

    equationA

    .o7 JtK/0*)-/;/G>+

    w"ereA

    Jt is t"e time interval between measurements oftem#erature *)+

    ) is t"e tem#erature of sterilised #roduct at time *t+

    > is a tem#erature coefficient w"ic" measures t"e

    number of de$rees required to c"an$e t"e D-value of

    an or$anism by / lo$

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    25/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%25

    6alidation - (ycle Develo#ment

    )"e minimum .o required by a sterilzation

    #rocess is related to t"e resistance of t"e

    bioburden *D-value+

    .o7 D/;/*3o$2 - 3o$ !+

    w"ereA D/;/ is equal to t"e time at /;/B( to reduce t"e

    #o#ulation of t"e most resistant or$anism in eac"

    #roduct container by 809 *or / lo$+

    2 is t"e number of microo$anisms #er container ! is t"e ma&imum acce#table #robability of

    survival *Sterility 2ssurance 3evel , /0-1+

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    26/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%26

    6alidation - (ycle Develo#ment

    )wo a##roac"es to sterilization Over4ill

    'robability of survival

    Over4ill a##roac" used w"en t"e #roduct

    can wit"stand e&cessive "eat treatment

    wit"out adverse effects

    (ycle s"ould deliver an .oof at least /;

    )"is will ac"ieve a /; lo$ reduction of microor$anisms

    wit" a D-value of / minute

    *2ssumin$ eac" #roduct unit contains /01or$anisms a /; lo$reduction will result in /0-1or$anisms #er unit or #robability

    of survival *S23+ of / in a million+

    *5ormal bioburden is usually muc" lower and t"e or$anisms

    normally muc" less resistant t"an t"is+

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    27/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%27

    6alidation - (ycle Develo#ment!iolo$ical Indicators

    device consistin$ of a 4nown number of

    microor$anisms, of a 4nown resistance to a

    #articular sterilization #rocess in or on a carrier

    and enclosed in a #rotective #ac4a$e=

    Or$anisms are in t"e form of endos#ores *not

    ve$etative state+ as t"ese are most resistant tosterilization

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    28/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%28

    6alidation - (ycle Develo#mentS#ore Stri#s - a narrow stri# of

    fibrous #a#er im#re$nated wit" a

    bacterial s#ore sus#ension

    contained in a $lassine envelo#e

    S#ore Dots - (ircular #ieces offibrous #a#er im#re$nated wit"

    t"e s#ore sus#ension

    S#ore Sus#ensions- #ure s#oresus#ension of t"e desired

    c"allen$e or$anism w"ic" can be

    inocluated onto t"e surface of a

    material

    Self contained units containin$ s#ore

    stri#s or sus#ensions and t"e

    media in w"ic" t"ey are to be

    incubated *sim#leGconvenient to

    use+

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    29/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%29

    6alidation - (ycle Develo#ment 'robability of Survival a##roac" used used

    for "eat labile #roducts)"e #rocess is validated to

    ac"ieve a destruction of t"e

    #resterilization bioburden to

    a level of /00*'oint L+, wit" a

    minimum safety factor of anadditional si&-lo$ reduction

    *'oint >+

    Determination of t"e

    minimum .o

    required is based

    on t"e bioburden and its "eat

    resistance

    "at .owould be required for a bioburden of /0;*/00+ if D-value was /

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    30/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%30

    6alidation of Sterilization

    !asic 'rinci#les

    Installation ualification *I+

    :nsurin$ equi#ment is installed as #er

    manufacturerNs s#ecification

    O#eration ualification *O+ :nsurin$ equi#ment, critical control equi#mentand instrumentation are ca#able of o#eratin$

    wit"in required #arameters

    'erformance ualifcation *'+ Demonstratin$ t"at sterilizin$ conditions are

    ac"ieved in all #arts of sterilization load

    '"ysical and microbiolo$ical

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    31/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%31

    6alidation - :qui#ment

    Installation ualification

    :nsurin$ equi#ment is installed as #er

    manufacturerNs s#ecification

    considerations for new and e&istin$ equi#ment

    s#ecifications for t"e ty#e of autoclave,construction materials, #ower su##lies and

    su##ort services, alarm and monitorin$

    systems wit" tolerances and accuracy

    requirements for e&istin$ equi#ment documented evidence

    t"at t"e equi#ment can meet #rocess

    s#ecifications

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    32/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%32

    6alidation - :qui#ment

    O#erational ualification

    :nsurin$ equi#ment, critical control

    equi#ment and instrumentation are ca#able

    of o#eratin$ wit"in required #arameters

    )"ree or more test runs w"ic" demonstrate controls, alarms, monitorin$ devices and o#eration

    indicators function

    c"amber #ressure inte$rity is maintained

    c"amber vacuum is maintained *if a##licable+

    written #rocedures accurately reflect equi#ment o#eration

    #re-set o#eration #arameters are attained for eac" run

    6 lid i ' f

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    33/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%33

    6alidation - 'erformance

    'erformance ualification

    Demonstratin$ t"at sterilizin$ conditions are

    ac"ieved in all #arts of sterilization load

    '"ysicaland microbiolo$ical

    '"ysical %eat distribution studies on em#ty c"amber

    ma&imum and minimum cycle times and tem#eratures

    to identify "eat distribution #atterns includin$ slowest

    "eatin$ #oints

    mulit#le tem#erature sensin$ devices s"ould be used

    *t"ermocou#les+

    location of devices s"ould be documented and ensure t"at

    "eat distribution is uniform

    6 lid ti ' f

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    34/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%34

    6alidation - 'erformance

    'erformance ualification - '"ysical *;+

    %eat distribution of ma&imum and minimum

    c"amber load confi$urations

    multi#le t"ermocou#les t"rou$"out c"amber *not inside

    #roduct containers+ to determine effect of load

    confi$uration on tem#erature distribution tem#erature distribution for all loads usin$ all container

    sizes used in #roduction s"ould be tested

    #osition of t"ermocou#les s"ould be documented

    Slowest to "eatGcold s#ots in eac" run s"ould be

    documented, inlcudin$ t"e drain re#eat runs s"ould be #erformed to c"ec4 variability

    tem#erature distribution #rofile for eac" c"amber load

    confi$uration s"ould be documented

    6 lid ti ' f

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    35/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%35

    6alidation - 'erformance

    'erformance ualification - '"ysical *+

    %eat #enetration studies to detect t"e ma&imumand minimum tem#erature wit"in all loads

    all #arts of eac" load must be on contact wit" steam

    need to determine lowest and "i$"est tem#erature

    locations and slowest and fastest to "eat locations

    *measured inside #roduct containers+

    need to consider all variables suc" as container size,

    desi$n, material, viscosity of solution and fill volume=

    (ontainer wit" ma&imum fill volume and slowest to "eat

    solution s"ould be used

    ma&imum and minimum load confi$urations for eac"

    sterilization cycle usin$ routine cycle #arameters

    6 lid ti ' f

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    36/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%36

    6alidation - 'erformance

    'erformance ualification - '"ysical *E+

    %eat #enetration *;+ May be necessary for container ma##in$ for lar$er

    volumes - cold s#ot t"en used for #enetration studies

    5eed to consider effects of #ac4a$in$ e=$=

    overwra##in$

    )"ree runs #erformed once cold s#ots "ave been

    identified to demonstrate re#roducibility

    6 lid ti ' f

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    37/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%37

    6alidation - 'erformance

    'erformance ualification - Microbiolo$ical

    !iolo$ical c"allen$e studies used w"en 'robability of Survival a##roac" is used

    may not be necessary w"en cycle is /;/B( for /C minutes

    *e&ce#t @S and 2ustralia+

    biolo$ical indicators *!I+ containin$ s#ores of Geobacillusstearothermophilusare most commonly used *considered

    worst case+= !Is containin$ ot"er or$anisms may be used

    #erformance studies based on #roduct bioburden require a

    considerable amount of wor4

    indicators s"ould be #laced t"rou$"out t"e load, adjacent to

    t"ermocou#les, at cold s#ots and slowest to "eat locations

    *identified durin$ "eat #enetration studies+

    any $rowt" is unacce#table unless #rocessin$ errors

    demonsrated

    6 lid ti ' f

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    38/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%38

    6alidation - 'erformance

    6alidation re#ort must demonstrate requirements

    in 6alidation #rotocol "ave been met, anydeviations must be justified

    Requalification must be re#eated on an annual

    basis *usually one run is acce#table+

    2ny c"an$es or modifications must be evaluated

    may just require requalification

    any c"an$es to loadin$ #atterns, new containerGclosure

    systems or cycle #arameters require full validation

    R ti ' d ti

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    39/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%39

    Routine 'roduction

    Issues considered for routine #roduction

    Manufacturin$ environment s"ould be controlled

    'rocedures in #lace to minimize t"e #re-

    sterilization bioburden

    bioburden limits s#ecified *alt"ou$" not so im#ortant

    w"en over4ill cycle used+

    )ime between fillin$ and sterilization s"ould be

    s#ecified

    Inte$rity of containerGclosure system s"ould be

    #eriodically verified 'eriodic lea4 testin$ of c"amber *if vacuum is #art

    of cycle+

    R ti ' d ti

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    40/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%40

    Routine 'roduction

    (oolin$ water s"ould be sterile

    Differentiation between sterilized and not-yet

    sterilized #roduct

    '"ysical se#aration *double ended autoclave+

    3abellin$ and use of visual indicators *e=$

    autoclave ta#e+

    'eriodic testin$ of containers to verify inte$rity of

    containerGclosure system

    uality of steam s"ould be defined and

    #eriodically tested for contaminants

    R ti ' d ti

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    41/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%41

    Routine 'roduction

    :ac" sterilization cycle must be monitored

    tem#erature, time and #ressure recorded

    tem#erature recorder inde#endent from cycle

    controller

    second inde#endent tem#erature recorder drain tem#erature s"ould be recorded

    c"emical and biolol$ical indicators *if

    a##licable+

    Sterilisation cycle records s"ould form

    #art of batc" records

    Ot" St ili ti '

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    42/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%42

    Ot"er Sterilization 'rocesses

    Sterilization usin$ ot"er #rocesses s"ould

    follow a similar a##roac" as t"at

    described for moist "eat

    6alidation #rotocol

    :qui#ment calibration Determinin$ t"e #rocess t"at will deliver t"e

    desired S23 */0-1+

    I, O, '

    Requirements for routine monitorin$ andcontrol

    Ot" St ili ti '

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    43/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%43

    Ot"er Sterilization 'rocesses

    Dry %eat

    S"ould "ave air circulation in t"e c"amber

    'ositive #ressure in t"e c"amber to #revent

    entry of non-sterile air

    %:'2 filtered air su##lied !iolo$ical indicators containin$ Bacillus

    atropheus *if used+

    removal of endoto&in is usually sufficient

    "en removin$ #yro$ens need to validate#rocess usin$ c"allen$e tests

    Ot"er Sterili ation 'rocesses

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    44/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%44

    Ot"er Sterilization 'rocesses

    Radiation

    @sually #erformed by contractin$ service

    *need to ensure validation status,

    res#onsibilities+

    !ased on bioburden of #roduct bein$

    sterilised

    !iolo$ical indicators may be used as additional

    control but may not be as resistant as naturally

    occurin$ bioburden

    Met"od defined in International Standard ISO///H

    Ot"er Sterilization 'rocesses

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    45/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%45

    Ot"er Sterilization 'rocesses

    Radiaton *;+

    (orrect dose of radiation *P;C 4?y+ received

    by all #roducts *measured wit" dosimeters+

    quantitative measurement

    number, location, wit"in calibration time-limit

    Radiation sensitive colour discs a##lied to

    #ac4a$in$

    #rocedures to distin$uis" irradiated and non-

    irradiated materials

    6ariation in density of #ac4a$in$ s"ould be

    addressed durin$ validation

    Ot"er Sterilization 'rocesses

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    46/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMPinspectors - Nanjin! Novem"er #$$%46

    Ot"er Sterilization 'rocesses

    ?asses and .umi$ants

    e=$= et"ylene o&ide, "ydro$en #ero&ide va#our

    Only w"en no ot"er met"od is suitable

    Must demonstrate t"at #rocess does not

    adversely affect #roduct 'ac4a$in$ must be able to #ermit in$ress of

    $as and "umidity

    :nsure #roduct load is adequately "eated and

    "umidified #rior to sterilization *calledconditionnin$+

    need to ta4e into account validation #erformed in

    summer or winter

    Ot"er Sterilization 'rocesses

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    47/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMP

    inspectors - Nanjin! Novem"er #$$%47

    Ot"er Sterilization 'rocesses

    ?asses and .umi$ants *;+

    )em#erature distribution is acce#table

    (oncentration of sterilant $as is sufficient

    @se of biolo$ical indicators is im#ortant

    *Bacillus atropheus+

    %alf cycles If cycle of "alf normal time destroys biolo$ical indicators */01

    or$anisms+, double time will ac"ieve S23 of /0 -1

    2eration

    6entilated conditions Defined limits of residuals

    'rocess included in validation

    Safety and to&icity issues considered

    @seful 'ublications

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    48/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMP

    inspectors - Nanjin! Novem"er #$$%48

    @seful 'ublications

    ISOG:5 /H11C - Sterilization of health care

    products - Moist Heat *'arts / and ;+

    ISOG:5 ///C - Sterilization of health care

    products - Ethylene Oxide *'arts / and ;+

    ISOG:5 ///H - Sterilization of health care

    products - Radiation *'arts /,; and +

    alidation of Moist Heat Sterilization !rocesses"

    #ycle $esi%n& $e'elopment& (ualification and

    on%oin% #ontrol)'D2 )ec"nical Re#ort 5o= /

    Revised ;00H

  • 7/26/2019 1-2 SterilisationValidationQualification (1)

    49/49

    Manufacture of sterile medicines Advanced workshop for SFDA GMP

    uestions